| 1 | Betaseron (interferon BETA-1B, BAY86-5046), bayer healthcare AG | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 2 | Extavia (interferon BETA-1B), novartis pharma AG | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 3 | Interferon BETA-1B | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 4 | Interferon BETA-1B and tacrolimus | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 5 | Interferon BETA-1B group | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 6 | Interferon BETA-1B, FRP about 6 weeks after randomization | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 7 | Interferon BETA-1B, FRP within 15 days after randomization | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 8 | Interferon BETA-1B/atorvastatin group | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 9 | Recombinant interferon BETA-1B | 2件: Human interferon betaHuman interferon beta, Interferon beta-1b (Interferon beta-1b)
 | 2件: Interferon beta-1bInterferon beta-1b
                
             (Interferon beta-1b, Interferon beta-1b), Interferon beta
                
             💬
 | 2件: IFNAR1IFNAR1, IFNAR2 💬
 | 18件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 1313 💬 | 
| 10 | SC interferon BETA-1B | - | - | - | - | 1件: 1313 💬 |